 BOSTON, Jan. 08, 2021 GLOBE NEWSWIRE -- Galecto, Inc., NASDAQ: GLTO a NASDAQ listed biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced the appointment of Dr. Anne Prener to its Board of Directors. 